SEPTIN9 and colorectal carcinoma: At the epigenetic level, some years ago, methylation of the SEPT9 gene promoter was indicated to be a promising biomarker for early diagnosis of CRC [22]; however, this test did not distinguish optimally CRC from polyps or adenomas, and thus it has not replaced colonoscopy in early screening [23].